cuprizone has been researched along with Adipocere in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amor, S; Bazinet, RP; Hildebrand, KD; Kipp, M; Nyamoya, SD; Trépanier, MO | 1 |
| Bai, B; Baranzini, SE; Chang, A; Chomyk, AM; Deckard, SA; Doud, MK; Dutta, R; Edberg, DD; Fox, RJ; Li, M; Macklin, WB; Ribaudo, MV; Staugaitis, SM; Trapp, BD | 1 |
2 other study(ies) available for cuprizone and Adipocere
| Article | Year |
|---|---|
Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue.
Topics: Adult; Aged; Aged, 80 and over; Animals; Brain; Chelating Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Female; Humans; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Sclerosis; Myelin Sheath; Oleic Acid; Phosphatidylcholines; Postmortem Changes | 2018 |
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.
Topics: Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Humans; Immunosuppressive Agents; Memory Disorders; Mice; MicroRNAs; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Neurons; Postmortem Changes; Receptors, AMPA; RNA, Messenger; Sirolimus | 2013 |